GPT and fatty liver disease: Moreover, even though a few non-specific markers, such as AST and ALT, were employed in this non-randomized trial, hepatic steatosis was not assessed by accurate imaging methods (e.g., ultrasound or magnetic resonance) [99], which ultimately restrained our discussion on liver status to general markers.